Amanda Feilding - Selected Publications

Selected Publications

Fully updated lists of Amanda Feilding's and Beckley Foundation scientific and drug policy> publications are available at the Beckley Foundation website.

Beckley Foundation Press

The Beckley Foundation’s Global Cannabis Commission was convened by Amanda Feilding in 2006. Its findings were presented at a Meeting at the House of Lords in 2008. The findings were initially published in Report form as: The Global Cannabis Commission Report, subtitled Cannabis Policy: Moving Beyond Stalemate. The Global Commissioners were Robin Room, Benedikt Fischer, Wayne Hall, Simon Lenton, Peter Reuter and Amanda Feilding. The authors of the Report were Robin Room, Benedikt Fischer, Wayne Hall, Simon Lenton and Peter Reuter.

Hofmann’s Elixir: LSD and the New Eleusis Edited by Amanda Feilding Talks & Essays by Albert Hofmann and others Beckley Foundation Press (2010).

Book chapters

Reviewing the UN Drug Conventions: Cannabis and Psychedelics, Amanda Feilding. In Controversies on the Regulation of Traditional Drug Use, Bia Labate and Clancy Cavnar (eds), Accepted by Springer-Wiley.

The Resurrection of Psychedelic Research, Amanda Feilding. In Harm Reduction in Substance Use and High-Risk Behaviour, Richard Pates and Diane Riley (eds), Wiley-Blackwell (2012), pp. 246−51.

Amanda Feilding's Scientific Papers and Publications

Beckley Foundation/Imperial College Psychedelic Research Programme: Amanda Feilding in collaboration with Prof David Nutt and Dr Robin Carhart-Harris Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Carhart-Harris RL, Feilding A, Nutt DJ et al. Proceedings of the National Academy of Sciences of the USA, 2012, 109(6) 2138–43.

Beckley Foundation Collaboration with University College London: Amanda Feilding in collaboration with Prof Valerie Curran and Dr Celia Morgan Investigating the interaction between schizotypy, divergent thinking and cannabis use Schafer G, Feilding A, Morgan CJA et al. Consciousness and Cognition, 2012, 21:292–98.

Beckley Foundation Collaboration with King’s College London, Institute of Psychiatry: Amanda Feilding in collaboration with Dr Paul Morrison Cannabidiol inhibits THC-elicited psychosis and hippocampal-dependent memory impairment Englund A, Morrison P, Feilding A et al. In proof, 2012.

Disruption of Frontal Theta Coherence by Δ(9)-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms Morrison PD, Nottage J, Stone JM et al. Neuropsychopharmacology, 2011, 36(4):827–36. (Beckley Foundation-supported study)

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology Bhattacharyya S, Morrison PD, Fusar-Poli P, et al. Neuropsychopharmacology, 2010, 35(3):764-74. (Beckley Foundation-supported study)

Beckley Foundation Collaboration with Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences: Non-Invasive Evaluation of Human Brain Fluid Dynamics and Skull Biomechanics in Relation to Cognitive Functioning Moskalenko Y, Feilding A and Halvorson P. Published by Beckley Foundation Press (2009)

Relation of Age Cognitive Disorders with Cranial Compliance, Cerebrospinal Fluid Mobility and Cerebral Circulation Moskalenko Y Feilding A et al. International Journal of Pathophysiology, 2008, 69(3):307.

Beckley Foundation Collaboration with Freiburg University: Amanda Feilding in collaboration with Prof Thilo Hinterberger Neurophysiological correlates to psychological trait variables in experienced meditative practitioners Thilo Hinterberger, Amanda Feilding et al. In Neuroscience, Consciousness and Spirituality, H. Walach, S. Schmidt & W. Jonas (eds), Berlin: Springer (2011), pp. 129−57.